GE Healthcare partners with Roche to develop clinical decision support solutions: 5 things to know

Written by Mackenzie Garrity | January 11, 2018 | Print  |

GE Healthcare and Roche, a diagnostic developer, signed a long-term partnership to co-develop and market digital clinical decision support solutions.

Here are five things to know:

 

1. Initially, the two will focus on developing products that accelerate and improve individualized treatment options for cancer and critical care patients.

 

2. Roche and GE hope to develop a digital platform that uses advanced analytics to provide workflow solutions as well as apps to support clinical decisions.

 

3. The new solutions will enable integration of in-vivo and in-vitro data, patient records, medical best practices, real-time monitoring and research outcomes. Clinicians will also have decision support to provide correct treatment and quality care to patients.

 

4. GE is a leader in medical imaging equipment, and Roche is global leader in in-vitro diagnostics.

 

5. “This is the first time that two major players in healthcare have combined advanced analytics with in-vivo and in-vitro diagnostics to this degree,” said Kieran Murphy, GE Healthcare CEO and president. “We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients

and the healthcare industry.”

 

More articles on imaging:
Prince William scrubs in to observe surgery using da Vinci Surgical System: 4 takeaways
China performs 1st robotic surgery: 5 things to know
The da Vinci Surgical System Xi arrives at Gulf Coast Regional Medical Center: 4 takeaways

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.